News search

    E.g., 27/07/2024
    E.g., 27/07/2024
    La Dra. Guadalupe Sabio en su laboratorio.
    About the CNIC
    25 Oct 2017
    Dr. Guadalupe Sabio joins the EMBO’s network of young researchers

    Dr. Sabio leads a research group at the Carlos III National Cardiovascular Research Center (CNIC) whose main line of research are diseases related to obesity, like cardiovascular diseases, diabetes and liver cancer.


    About the CNIC
    18 Oct 2017
    Launch of the “Alliance of Severo Ochoa Centres and Maria de Maeztu Units of Excellence”
    • The Secretary of State for R&D+i, Carmen Vela, chaired the kickoff meeting of the new Severo Ochoa and Maria Maeztu Alliance of Excellence.
    • The alliance’s target is to internationally promote and strengthen the centres and units accredited with this distinction, to give their research a higher profile.
    Nuria Matesanz, Guadalupe Sabio, Elena Rodríguez, José Antonio Enríquez Ana Victoria Lechuga-Vieco, Maria Crespo-Ruiz, Luis Leiva-Vega y Alfonso Mora (centro).
    Research
    11 Oct 2017
    Nature Communications: A specific protein regulates the burning of body fat to generate heat

    The study published in Nature Communications, shows that the elimination of this protein from obese mice blocks any further increase in obesity and reduces body weight
    The best way to start the day. A ‘high-energy’ breakfast could consist of a cup of coffee, milk or yogurt, fruit, and wholemeal bread with tomato and olive oil
    Research
    3 Oct 2017
    JACC: Confirms the importance of breakfast in the prevention of cardiovascular disease

    The PESA study shows that people who regularly eat a ‘low energy’ breakfast (supplying less than 5% of recommended daily calorie intake) double their risk of developing atherosclerosis independently of classical cardiovascular risk factors
    From left to right. Cristina Clavería, Daniel Jimenez-Carretero, Laura Fernandez de Manuel, Covadonga Díaz-Díaz, María Montoya y Miguel Torres.
    Research
    26 Sep 2017
    Developmental Cell: A ‘social control’ system guarantees embryonic stem cell purity

    This control mechanism is important for pluripotency in the development of mammalian embryos 
    From left to right. Vicente Andres, Director of Basic Research of the CNIC; Mr. Makoto Suematsu, the President of the Japanese Agency for Research and Medical Development (AMED); Borja Ibáñez, Director of Clinical Research at the CNIC; Mr. Masahiko Noda, Managing Director of the Foreign Affairs Department, Alberto Sanz, Managing Director of the CNIC, and the First Secretary - Aggregate of Science and Technology – of the Japanese Embassy in Spain, Mr. Masahiro Aoki
    About the CNIC
    13 Sep 2017
    The Japanese Agency for Research and Medical Development at the CNIC

    The Japanese Agency for Research and Medical Development (AMED) is an institution dedicated to improving medicine through research and development in Japan
    Photo 1: The authors are holding in their hands illustrations of cells expressing different combinations of membrane and nuclei fluorescent proteins. This corresponds to the method we developed (present in the article) to differentially label cells expressing different genes (with the codes A to F). Each cell expresses a different combination of 2 genes from a pool of 6 different genes (A, B, C, D, E, and F).
    Publications
    10 Aug 2017
    Cell: CNIC Scientists develop new methods for analyzing gene function

    The study, published in Cell, will allow any researcher to induce multispectral genetic mosaics in vertebrate research models such as mice and zebrafish
    The CNIC research team. From left to right: Andrés Hidalgo, David Sancho, Sarai Martínez-Cano, Salvador Iborra, Elena Priego, Michel Enamorado, and Juan Antonio Quintana.
    Research
    17 Jul 2017
    `'Nature Comunications': Scientists Find the Key to Improved Cancer Immunotherapy

    The study, published in Nature Communications, demonstrates that tissue-resident and circulating memory T cells cooperate in anti-tumor immunity
    About the CNIC
    1 Jun 2017
    Dr. Borja Ibáñez awarded the XII Banco Sabadell Foundation Award for Biomedical Research

    Dr. Ibáñez, Director of Clinical Research at the CNIC, has received an award for his contribution to the fight against cardiovascular diseases
    Alberto Sanz, Gerente del CNIC; Dr. Jordi Camí, director de la Fundación Pasqual Maragall; Dr. Valentín Fuster, director general del CNIC, y Dr. Borja Ibáñez, Director de Investigación Clínica del CNIC.
    About the CNIC
    30 May 2017
    Two of the of the largest research cohorts in Spain join together to work on the prevention of atherosclerosis and Alzheimer’s

    Los resultados permitirán avanzar en el conocimiento de la interacción entre los diversos factores de riesgo de ambas enfermedades